Title: Substrate specificity and inhibitor analyses of human steroid 5ýý-reductase (AKR1D1).

Authors: Chen, Mo; Drury, Jason E; Penning, Trevor M

Published In Steroids, (2011 Apr)

Abstract: Human steroid 5ýý-reductase (aldo-keto reductase 1D1) catalyzes the stereospecific NADPH-dependent reduction of the C4-C5 double bond of ýý(4)-ketosteroids to yield an A/B cis-ring junction. This cis-configuration is crucial for bile acid biosynthesis and plays important roles in steroid metabolism. The biochemical properties of the enzyme have not been thoroughly studied and conflicting data have been reported, partially due to the lack of highly homogeneous protein. In the present study, we systematically determined the substrate specificity of homogeneous human recombinant AKR1D1 using C18, C19, C21, and C27 ýý(4)-ketosteroids and assessed the pH-rate dependence of the enzyme. Our results show that AKR1D1 proficiently reduced all the steroids tested at physiological pH, indicating AKR1D1 is the only enzyme necessary for all the 5ýý-steroid metabolites present in humans. Substrate inhibition was observed with C18 to C21 steroids provided that the C11 position was unsubstituted. This structure activity relationship can be explained by the existence of a small alternative substrate binding pocket revealed by the AKR1D1 crystal structure. Non-steroidal anti-inflammatory drugs which are potent inhibitors of the related AKR1C enzymes do not inhibit AKR1D1. By contrast chenodeoxycholate and ursodeoxycholate were found to be potent non-competitive inhibitors suggesting that bile-acids may regulate their own synthesis at the level of AKR1D1 inhibition.

PubMed ID: 21255593

MeSH Terms: Bile Acids and Salts/metabolism; Binding Sites; Crystallography, X-Ray; Humans; Hydrogen-Ion Concentration; Ketosteroids/metabolism; Kinetics; Oxidoreductases/antagonists & inhibitors; Oxidoreductases/chemistry*; Oxidoreductases/metabolism; Structure-Activity Relationship; Substrate Specificity